Comparative Pharmacokinetics and Metabolic Pathway of Gemcitabine During Intravenous and Intra-arterial Delivery in Unresectable Pancreatic Cancer Patients

Author： Shamseddine Ali I.  

Publisher： Adis International

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.44, Iss.9, 2005-01, pp. : 957-967

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intra-arterial gemcitabine for unresectable pancreatic cancer

By  

Inpharma, Vol. 1, Iss. 1504, 2005-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

A phase 2 study of oral MKC-1, an inhibitor of importin-β, tubulin, and the mTOR pathway in patients with unresectable or metastatic pancreatic cancer

By Faris Jason  

Investigational New Drugs, Vol. 30, Iss. 4, 2012-08 ,pp. : 1614-1620

Springer Publishing Company

Access to resources Recommend Favorite

Combined intravenous and intra-arterial approach in acute stroke treatment

By Almekhlafi Mohammed A   Hill Michael D  

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 12, 2007-08 ,pp. : 1837-1849

Informa Healthcare

Access to resources Recommend Favorite

Pathway-based pharmacogenomics of gemcitabine pharmacokinetics in patients with solid tumors

By Mitra Amit K   Kirstein Mark N   Khatri Amit   Skubitz Keith M   Dudek Arkadiusz Z   Greeno Edward W   Kratzke Robert A   Lamba Jatinder K  

Pharmacogenomics, Vol. 13, Iss. 9, 2012-07 ,pp. : 1009-1021

Future Medicine

Access to resources Recommend Favorite

Intra-arterial pharmacokinetics and pulmonary first-pass of levamisole in rabbits

By Pereda P.   García J.J.   Sierra M.   Fernández N.   Sahagun A.M.   Jose Diez M.  

Pharmacological Research, Vol. 45, Iss. 4, 2002-04 ,pp. : 285-289

Academic Press

Access to resources Recommend Favorite